FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series D or later / Biotech startups that raised Series D or later in Massachusetts, United States

Biotech startups that raised Series D or later in Massachusetts, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series D or later in Massachusetts, United States
One-time CSV
  • 40 funded companies, 34 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-d-plus~massachusetts-united-states.csv40 rows × 18 columns
CompanyCityLast roundAmountDate
AlzheonFraminghamSeries F$78.8M2026-09-10
ElucidBostonSeries D$36.5M2025-10-22
VariantyxFraminghamSeries D$36.0M2025-04-01
Insilico MedicineCambridgeSeries E$123.0M2025-03-13
InariCambridgeSeries G$144.0M2025-01-07
SeLux DiagnosticsCharlestownSeries D$48.0M2024-04-01
EmulateBostonSeries F$47.1M2024-03-20
Lyndra TherapeuticsWatertownSeries E$101.0M2023-12-21

8 rows of the CSV in 5 of its 18 columns.

40
Startups
$7.3B
Total raised
6
Funded in the last 12 months
$500.8M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

9 of 40
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Alzheon Alzheon develops treatments for neurodegenerative disorders as a clinical-stage biotechnology company. Biotech Framingham Series F $78.8M 2026-09-10 $343.3M Ally Bridge Group, National Institute on Aging 11 to 50 2013
Elucid Elucid applies AI to medical images to support precision medicine for cardiovascular disease. Biotech Boston Series D $36.5M 2025-10-22 $166.2M National Science Foundation, Sand Hill Angels, IAG Capital Partners +1 101 to 250 2013
Variantyx Variantyx offers molecular diagnostics and advanced genetic testing services. Biotech Framingham Series D $36.0M 2025-04-01 $136.5M Pitango VC, Bosch Ventures, Kreos Capital +2 101 to 250 2014
Insilico Medicine Insilico Medicine develops an AI platform for drug development targeting cancer and age-related diseases. Artificial intelligence Cambridge Series E $123.0M 2025-03-13 $624.3M Qiming Venture Partners, F-Prime, Warburg Pincus +1 101 to 250 2014
Inari Unicorn Inari is a seed design and biotechnology company developing seeds for a nature-positive food system. Biotech Cambridge Series G $144.0M 2025-01-07 $753.0M EDBI, Alexandria Venture Investments, CPP Investments +2 251 to 500 2016
Emulate Emulate creates advanced in vitro models to study how diseases, medicines, and chemicals affect human health. Biotech Boston Series F $47.1M 2024-03-20 $271.3M Alumni Ventures, Qiming Venture Partners, National Institutes of Health 51 to 100 2013
Lyndra Therapeutics Lyndra Therapeutics creates oral dosage forms that release drugs over the long term. Biotech Watertown Series E $101.0M 2023-12-21 $284.6M Polaris Partners, Bill & Melinda Gates Foundation, Invus 51 to 100 2015
Biofourmis Unicorn Biofourmis develops healthcare technology platforms that monitor patients at home. Artificial intelligence Boston Series D $20.0M 2022-07-27 $463.6M Sequoia Capital, Intel Capital, Peak XV Partners +1 251 to 500 2015
Finch Therapeutics Finch Therapeutics develops microbiome-based treatments for patients with serious unmet medical needs. Artificial intelligence Somerville Series D $90.0M 2020-09-17 $188.8M Avenir, DFO Management, Willett Advisors LLC +1 11 to 50 2017

Table 1. Biotech startups that raised Series D or later in Massachusetts, United States: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 40.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Alzheon Alzheon develops treatments for neurodegenerative disorders as a clinical-stage biotechnology company. Biotech Framingham Series F $78.8M 2026-09-10 $343.3M Ally Bridge Group, National Institute on Aging 11 to 50 2013

Table 2. Biotech startups that raised Series D or later in Massachusetts, United States: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Deerfield Hedge fund New York, United States 2 5%
2 Qiming Venture Partners Venture capital firm Shanghai, China 2 5%
3 EDBI Venture capital firm Singapore 2 5%
4 RA Capital Management Startup incubator Boston, United States 2 5%
5 National Institutes of Health Entrepreneurship program Bethesda, United States 2 5%
6 Ally Bridge Group Private equity firm Hong Kong 1 2% 1 Alzheon
7 National Institute on Aging Government investment office Bethesda, United States 1 2% 1 Alzheon
8 Aphelion Capital Micro VC fund Littleton, United States 1 2%
9 IAG Capital Partners Venture capital firm Charleston, United States 1 2%
10 Sand Hill Angels Angel group Mountain View, United States 1 2%
11 National Science Foundation Entrepreneurship program Alexandria, United States 1 2%
12 Pitango VC Venture capital firm Herzliya, Israel 1 2%
13 Kreos Capital Venture capital firm London, United Kingdom 1 2%
14 New Era Capital Partners Venture capital firm Tel Aviv, Israel 1 2%
15 Bosch Ventures Corporate venture arm Stuttgart, Germany 1 2%

Table 3. Biotech startups that raised Series D or later in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 37 92% $6.3B
Software 6 15% $1.7B
Artificial intelligence 4 10% $1.4B
Energy 1 2%

Table 4. Biotech startups that raised Series D or later in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series D+ 40 100% $47.1M

Table 5. Biotech startups that raised Series D or later in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Cambridge 12 30%
Boston 5 12%
Waltham 3 8%
Framingham 2 5%
Beverly 2 5%
Watertown 2 5%
Billerica 2 5%
Somerville 2 5%
Lexington 2 5%
Bedford 2 5%
Newton 1 2%
Woburn 1 2%

Table 6. Biotech startups that raised Series D or later in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 1 17% $78.8M
August 2026 2 33% $254.0M
April 2026 2 33% $120.0M
January 2026 1 17% $48.0M

Table 7. Biotech startups that raised Series D or later in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 6 15% $500.8M
2025 6 15% $364.7M
2024 3 8% $240.1M
2023 3 8% $559.8M
2022 2 5% $130.0M
2021 3 8% $196.0M

Table 8. Biotech startups that raised Series D or later in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2015 to 2019 13 32%
2010 to 2014 13 32%
Before 2010 14 35%

Table 9. Biotech startups that raised Series D or later in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 2 5%
11 to 50 14 35%
51 to 100 12 30%
101 to 250 9 22%
251 to 500 3 8%

Table 10. Biotech startups that raised Series D or later in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Massachusetts, United States whose last round is Series D or later are on the list?
40, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 40 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series D or later in Massachusetts, United States: 40 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Massachusetts

Other sectors that raised Series D or later in Massachusetts

Cite: FundingWatcher, 40 biotech companies in Massachusetts, United States whose most recent round is Series D or later, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-d-plus/massachusetts-united-states/